Systematic review of intravenous methylene blue in parathyroid surgery (Q38041997)

27 August 2017

title

Systematic review of intravenous methylene blue in parathyroid surgery (English)

1 reference

27 August 2017

1 reference

H P Patel

1

1 reference

27 August 2017

D R Chadwick

series ordinal

2

1 reference

27 August 2017

B J Harrison

series ordinal

3

1 reference

27 August 2017

S P Balasubramanian

series ordinal

4

1 reference

27 August 2017

language of work or name

English

0 references

publication date

1 October 2012

1 reference

British Journal of Surgery

27 August 2017

published in

1 reference

27 August 2017

volume

99

1 reference

27 August 2017

issue

10

1 reference

27 August 2017

page(s)

1345-1351

1 reference

Methylene Blue for Rapid Identification of the Parathyroids

27 August 2017

cites work

1 reference

Intraoperative identification of parathyroid glands with methylene blue infusion.

21 January 2018

1 reference

Parathyroid identification by methylene blue infusion

21 January 2018

1 reference

Methylene blue and sestamibi: complementary tools for localizing parathyroids.

21 January 2018

1 reference

Intraoperative adjuncts in surgery for primary hyperparathyroidism

21 January 2018

1 reference

Methylene blue implicated in potentially fatal serotonin toxicity.

21 January 2018

1 reference

Adverse neurologic effect of methylene blue used during parathyroidectomy.

21 January 2018

1 reference

Methylene blue-associated serotonin syndrome: a 'green' encephalopathy after parathyroidectomy

21 January 2018

1 reference

Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use.

21 January 2018

1 reference

Diagnosis of a case of ectopic parathyroid adenoma on the early image of 99mTc-MIBI scintigram.

21 January 2018

1 reference

Prolonged postoperative altered mental status after methylene blue infusion during parathyroidectomy: a case report and review of the literature

21 January 2018

1 reference

Methylene-blue-associated encephalopathy

21 January 2018

1 reference

Serotonin syndrome following methylene blue infusion during parathyroidectomy: a case report and literature review

21 January 2018

1 reference

Hyperpyrexia and prolonged postoperative disorientation following methylene blue infusion during parathyroidectomy

21 January 2018

1 reference

Twice-recurrent primary hyperparathyroidism due to parathyroid hyperplasia in an ectopic supernumerary gland

21 January 2018

1 reference

Methylene blue toxicity following infusion to localize parathyroid adenoma.

21 January 2018

1 reference

Rapid intraoperative localization of parathyroid glands utilizing methylene blue infusion

21 January 2018

1 reference

Prolonged postoperative disorientation after methylene blue infusion during parathyroidectomy.

21 January 2018

1 reference

Thymic parathyroid carcinoma and postoperative hungry bone syndrome

21 January 2018

1 reference

Clinical outcomes and fiscal consequences of bilateral neck exploration for primary idiopathic hyperparathyroidism without preoperative radionuclide imaging or minimally invasive techniques.

21 January 2018

1 reference

Postoperative delirium indicating an adverse drug interaction involving the selective serotonin reuptake inhibitor, paroxetine?

21 January 2018

1 reference

An evaluation of the intraoperative staining technique using methylene blue for the detection of hyperplastic parathyroid glands.

21 January 2018

1 reference

Intraoperative identification of parathyroid glands: appraisal of methylene blue staining.

21 January 2018

1 reference

Neurological sequelae following methylene blue injection for parathyroidectomy.

21 January 2018

1 reference

Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BJS.8814

1 reference

27 August 2017

1 reference